Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHA/688513 stock hub

SHA/688513 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/688513is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/688513

In the news

Latest news · SHA/688513

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E36.2

P25 17.1P50 24.2P75 37.8

Trailing P/E39.9

P25 23.5P50 41.3P75 83.2

ROE9.1

P25 -0.9P50 4.1P75 8.8

ROIC13.6

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/688513 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

CNY

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,522
Employees Change	122%
Employees Change Percent	8.71
Enterprise value	CNY 9.5B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100004397
Last refreshed	2026-05-10
Market cap	CNY 11B
Price	CNY 63.03
Price currency	CNY
Rev Per Employee	888,318.1x
Sector	Healthcare
Sic	2834
Symbol	sha/688513
Website	https://www.eastonpharma.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.49%
EV Earnings	34.91x
EV/EBIT	32.24x
EV/Sales	7.06x
Forward P/E	36.22x
P/B ratio	3.56x
P/E ratio	39.88x
P/S ratio	8.13x
PE Ratio3 Y	30.54x
PE Ratio5 Y	28.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.9%
Gross margin	99.27%
Gross Profit	CNY 1.3B
Gross Profit Growth	1.08%
Gross Profit Growth Q	4.43%
Gross Profit Growth3 Y	1.25%
Gross Profit Growth5 Y	3.44%
Net Income	CNY 273.5M
Net Income Growth	22.56%
Net Income Growth Q	-16.11%
Net Income Growth Years	2%
Net Income Growth3 Y	2.64%
Net Income Growth5 Y	7.53%
Pretax Margin	21.03%
Profit Margin	20.23%
Profit Per Employee	CNY 179,691
Profitable Years	13
ROA	5.11
Roa5y	3.42
ROCE	9.19
ROE	9.09
Roe5y	9.7
ROIC	13.64
Roic5y	14.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	86.32%
Cagr3y	18.26%
Cagr5y	18.28%
Div CAGR3	-6.77%
EPS Growth	24.38
EPS Growth Q	-14.71
EPS Growth Years	2
EPS Growth3 Y	3.27
EPS Growth5 Y	5.56
FCF Growth	45.1%
FCF Growth Q	113.92%
OCF Growth	29.64%
OCF Growth Q	95.18%
OCF Growth3 Y	28.26%
OCF Growth5 Y	13.59%
Revenue Growth	0.87x
Revenue Growth Q	6.75x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	4.66x
Revenue Growth5 Y	6.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.37
Assets	CNY 3.8B
Cash	CNY 1.6B
Current Assets	CNY 2.1B
Current Liabilities	CNY 553.6M
Debt	CNY 81.3M
Debt Equity	CNY 0.03
Equity	CNY 3.1B
Interest Coverage	176.8
Liabilities	CNY 691.5M
Long Term Assets	CNY 1.7B
Long Term Liabilities	CNY 137.8M
Net Cash	CNY 1.5B
Net Cash By Market Cap	CNY 14.02
Net Cash Growth	14.09%
Net Debt Equity	CNY -0.5
Tangible Book Value	CNY 2.8B
Tangible Book Value Per Share	CNY 15.84
WACC	4.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.82
Inventory Turnover	0.04
Net Working Capital	CNY -8M
Quick ratio	3.32
Working Capital	CNY 1.6B
Working Capital Turnover	CNY 0.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.46%
Dividend Growth	-25.86%
Dividend Growth Years	0%
Dividend per share	CNY 0.43
Dividend Years	5
Dividend Yield	0.68%
Ex Div Date	2025-06-11
Last Dividend	CNY 0.43
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	86.25%
200-day SMA	59.17
3Y total return	65.42%
50-day SMA	63.81
50-day SMA vs 200-day SMA	50over200
5Y total return	131.45%
All Time High	80.48
All Time High Change	-21.68%
All Time High Date	2026-04-02
All Time Low	28.11
All Time Low Change	124.23%
All Time Low Date	2024-07-30
ATR	3.14
Beta	0.11
Beta1y	-0.49
Beta2y	-0.01
Ch YTD	2.41
High	63.35
High52	80.48
High52 Date	2026-04-02
High52ch	-21.68%
Low	62
Low52	32.55
Low52 Date	2025-05-15
Low52ch	93.64%
Ma50ch	-1.22%
Price vs 200-day SMA	6.53%
RSI	43.83
RSI Monthly	63.17
RSI Weekly	52.35
Sharpe ratio	1.01x
Sortino ratio	1.83
Total Return	2.15%
Tr YTD	2.41
Tr1m	-19.97%
Tr1w	-0.36%
Tr3m	-4.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 296.2M
Operating Income Growth	14.93
Operating Income Growth Q	-28.81
Operating Income Growth3 Y	12.05
Operating Income Growth5 Y	12.96
Operating margin	21.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	80,466,173%
Net Borrowing	-38,666,666
Shares Insiders	48.82%
Shares Institutions	10.95%
Shares Out	174,352,910
Shares Qo Q	3.91%
Shares Yo Y	-1.46%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,270,757.95x
Bv Per Share	17.13
Ch1m	-19.97
Ch1w	-0.36
Ch1y	84.46
Ch3m	-4.8
Ch3y	60.3
Ch5y	119
Ch6m	13.94
Change	0.13%
Change From Open	-0.51
Close	62.95
Days Gap	0.64
Depreciation Amortization	95,422,569
Dollar Volume	134,137,294.5
Earnings Date	2026-04-22
EBIT	CNY 296.2M
EPS	CNY 1.58
F Score	5
Fiscal Year End	December
Founded	2,009
Goodwill	23,099,384
Graham Number	24.68411
Graham Upside	-60.84
Income Tax	CNY 18.4M
Is Primary Listing	1
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Last Split Date	2024-07-01
Last Split Type	Forward
Lynch Fair Value	CNY 11.91
Lynch Upside	-81.11
Ma150	59.73
Ma150ch	5.52%
Ma20	66.04
Ma20ch	-4.56%
Next Earnings Date	2026-08-18
Open	63.35
Payment Date	2025-06-11
Position In Range	76.3
Ppne	1,212,575,138
Price Date	2026-05-08
Ptbv Ratio	3.98
Relative Volume	0.67x
Revenue	1,352,020,154x
Tax By Revenue	1.36x
Tax Rate	6.48%
Tr6m	13.94%
Volume	2,128,150
Z Score	9.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/688513 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.43 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+2.1%

Next ex-dividend date: 2025-06-11

Performance

SHA/688513 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/688513?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.9%

Share of float held by funds and institutions

Insider ownership

+48.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.5%

Negative means the company is buying back shares.

Technical

SHA/688513 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.8

Neutral momentum band

Price vs 200-day MA

+6.5%

50/200-day relationship not available

Beta (5Y)

0.11

Less volatile than the market

Sharpe ratio

1.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/688513

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688513 stock rating?

sha/688513 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688513 analysis?

The full report lives at /stocks/sha/688513/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688513?

The latest report frames sha/688513 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688513 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.